» Articles » PMID: 9872981

Homologs of the Yeast Longevity Gene LAG1 in Caenorhabditis Elegans and Human

Overview
Journal Genome Res
Specialty Genetics
Date 1999 Jan 5
PMID 9872981
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

LAG1 is a longevity gene, the first such gene to be identified and cloned from the yeast Saccharomyces cerevisiae. A close homolog of this gene, which we call LAC1, has been found in the yeast genome. We have cloned the human homolog of LAG1 with the ultimate goal of examining its possible function in human aging. In the process, we have also cloned a homolog from the nematode worm Caenorhabditis elegans. Both of these homologs, LAG1Hs and LAG1Ce-1, functionally complemented the lethality of a lag1delta lac1delta double deletion, despite low overall sequence similarity to the yeast proteins. The proteins shared a short sequence, the Lag1 motif, and a similar transmembrane domain profile. Another, more distant human homolog, TRAM, which lacks this motif, did not complement. LAG1Hs also restored the life span of the double deletion, demonstrating that it functions in establishing the longevity phenotype in yeast. LAG1Hs mapped to 19p12, and it was expressed in only three tissues: brain, skeletal muscle, and testis. This gene possesses a trinucleotide (CTG) repeat within exon 1. This and its expression profile raise the possibility that it may be involved in neurodegenerative disease. This possibility suggests at least one way in which LAG1Hs might be involved in human aging.

Citing Articles

An anomalous abundance of tryptophan residues in ceramide synthases based on analysis of all membrane proteins in the Swiss-Prot database.

Mestre B, Zelnik I, Izrailov S, Dingjan T, Lvovsky G, Fidel L J Biol Chem. 2024; 301(1):108053.

PMID: 39653242 PMC: 11742613. DOI: 10.1016/j.jbc.2024.108053.


Mechanism of Fumonisin Self-Resistance: Contains Four Fumonisin B-Insensitive-Ceramide Synthases.

Krska T, Twaruschek K, Wiesenberger G, Berthiller F, Adam G Toxins (Basel). 2024; 16(6).

PMID: 38922130 PMC: 11209526. DOI: 10.3390/toxins16060235.


GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.

Park A, Leney-Greene M, Lynberg M, Gabrielski J, Xu X, Schwarz B Nat Immunol. 2024; 25(2):282-293.

PMID: 38172257 PMC: 11151279. DOI: 10.1038/s41590-023-01691-y.


Structure and mechanism of a eukaryotic ceramide synthase complex.

Xie T, Fang Q, Zhang Z, Wang Y, Dong F, Gong X EMBO J. 2023; 42(24):e114889.

PMID: 37953642 PMC: 10711658. DOI: 10.15252/embj.2023114889.


Mechanisms of Nonvesicular Ceramide Transport.

Clausmeyer L, Frohlich F Contact (Thousand Oaks). 2023; 6:25152564231208250.

PMID: 37859671 PMC: 10583516. DOI: 10.1177/25152564231208250.